Swiss Medicines Regulator Responds To Trump's Paracetamol Claim

2025-09-25 02:12:53

(MENAFN- Swissinfo) The Swiss medicines regulator Swissmedic says the risk-benefit ratio of taking paracetamol during pregnancy remains positive, after United States President Donald Trump claimed the medicinal ingredient causes autism. This content was published on September 25, 2025 - 10:55 2 minutes Keystone-SDA

Deutsch de Schweizer Arzneimittelbehörde widerspricht Donald Trump Original Read more: Schweizer Arzneimittelbehörde widerspricht Donald Trum
Español es La autoridad reguladora suiza de medicamentos responde a la afirmación de Trump sobre el paracetamol Read more: La autoridad reguladora suiza de medicamentos responde a la afirmación de Trump sobre el paracetamo

+Get the most important news from Switzerland in your inbox

Swissmedic takes note of the fact that the US government considers a connection between the use of paracetamol during pregnancy and the occurrence of autism in children to be possible, Swissmedic said in a statementExternal link published on its website.

Several medicinal products containing the active ingredient paracetamol have been available in Switzerland for many years, including during pregnancy if necessary.

More More How drug prices are negotiated in Switzerland and beyond

This content was published on Apr 23, 2024 Switzerland's pharmaceutical sector supplies drugs worldwide, but not all countries receive them with the same price tag. Here's why.

Read more: How drug prices are negotiated in Switzerland and beyon

MENAFN25092025000210011054ID1110112030

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.